Generic Name: Letrozole Tablets
Letroz 2.5mg Tablets are a medication commonly prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
letrozole, which is classified as an aromatase inhibitor. Letrozole works by reducing the production of estrogen in the body, thereby slowing down the growth of estrogen-sensitive cancer cells.
Letrozole is primarily used for the treatment of breast cancer, specifically hormone receptor-positive breast cancer in postmenopausal women. These types of breast cancers are stimulated to grow by the hormone estrogen, and Letrozole helps to lower estrogen levels in the body.
By reducing the levels of estrogen, Letrozole inhibits the fuel source that certain breast cancer cells require for their growth and proliferation. This can slow down the progression of the disease and reduce the risk of recurrence.
Letrozole can be used as monotherapy in the treatment of advanced breast cancer, or as an adjuvant treatment following surgery or other primary therapies to reduce the risk of cancer recurrence.

• Customer-Centric Solutions: Parshva Agency focuses on delivering tailored private labeling services on a Peer-to-Peer (P2P) basis to meet the unique needs of each client.
• Regulatory Support: The agency is backed by experienced regulatory experts who ensure full compliance with all industry standards, providing peace of mind to clients.
• State-of-the-Art Manufacturing: Partnered with advanced manufacturing facilities that meet WHO-GMP certifications, Parshva Agency emphasizes the importance of modern production techniques.
• Quality and Efficacy: With WHO-GMP certification, the agency guarantees that its products maintain the highest standards of quality and efficacy.
• Reliability: Parshva Agency is committed to providing safe, reliable, and compliant products that meet stringent regulatory guidelines, fostering trust among clients and stakeholders.